EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Circulating tumor DNA–guided adjuvant immunotherapy in muscle-invasive bladder cancer

Kamil Malshy, Edward M Messing

Bladder Cancer · 2026-01 · 12 (1)

DOI: 10.1177/23523735261429862 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bladder Cancer, online erschienen am 02.03.2026. Verfasst von Kamil Malshy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Rochester Medical Center, Rochester, NY, USA. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rationale for adjuvant therapy after radical cystectomy

Schlagwörter

Stichwörter der Autor:innen

Imvigor011adjuvantbiomarkerbladder cancerctDNAimmunotherapymuscle invasive bladder canceroncological outcomesoverall survival

Autor:innen und Institutionen

  • Department of Urology, University of Rochester Medical Center, Rochester, NY, USA.

Zitieren

APA

Malshy, K., & Messing, E. M. (2026). Circulating tumor DNA–guided adjuvant immunotherapy in muscle-invasive bladder cancer. Bladder Cancer, 12(1). https://doi.org/10.1177/23523735261429862

Vancouver

Malshy K, Messing EM. Circulating tumor DNA–guided adjuvant immunotherapy in muscle-invasive bladder cancer. Bladder Cancer. 2026;12(1). doi:10.1177/23523735261429862

BibTeX
@article{Malshy2026,
  author = {Malshy, Kamil and Messing, Edward M},
  title = {Circulating tumor DNA–guided adjuvant immunotherapy in muscle-invasive bladder cancer},
  journal = {Bladder Cancer},
  year = {2026},
  volume = {12},
  number = {1},
  doi = {10.1177/23523735261429862}
}
Kostenlos starten →